Scilex Holding Company Patent Applications Rejected
8 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-12-27: Application 19003054; Invention ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN; Applicant Scilex Holding Company; Status Expressly Abandoned -- During Examination.
- 2024-11-04: Application 18935972; Invention METHODS OF TREATING PAIN; Applicant Scilex Holding Company; Status Abandoned -- Incomplete Application (Pre-examination).
- 2024-05-14: Application 18664015; Invention ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN; Applicant Scilex Holding Company; Status Abandoned -- Incomplete Application (Pre-examination).
- 2023-01-27: Application 18160878; Invention ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN; Applicant Scilex Holding Company; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-12-27 | 19003054 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | Scilex Holding Company | Expressly Abandoned -- During Examination | US20250127714A1 | Sagar MUNJAL Ankit BAHETI Bijay Kumar PADHI Supritha VAKADA Rajeev Singh RAGHUVANSHI | United States India India India India | CENTRAL, DOCKET |
| 2024-11-04 | 18935972 | METHODS OF TREATING PAIN | Scilex Holding Company | Abandoned -- Incomplete Application (Pre-examination) | Sagar Munjal Anirudh Gautam | United States United States | ||
| 2024-05-14 | 18664015 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | Scilex Holding Company | Abandoned -- Incomplete Application (Pre-examination) | Sagar MUNJAL Ankit BAHETI Bijay Kumar PADHI Supritha VAKADA Rajeev Singh RAGHUVANSHI | United States India India India India | ||
| 2023-01-27 | 18160878 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | Scilex Holding Company | Abandoned -- Failure to Respond to an Office Action | US20240016732A1 | Sagar Munjal Ankit Baheti Bijay Kumar Padhi Supritha Vakada Rajeev Singh Raghuvanshi | United States India India India India | BARSKY, JARED |
| 2022-11-15 | 17987808 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | Scilex Holding Company | Abandoned -- Incomplete Application (Pre-examination) | Sagar Munjal Ankit Baheti Bijay Kumar Padhi Supritha Vakada Rajeev Singh Raghuvanshi | United States India India India India | ||
| 2022-08-22 | 17892854 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | Scilex Holding Company | Abandoned -- Incomplete Application (Pre-examination) | Sagar Munjal Ankit Baheti Bijay Kumar Padhi Supritha Vakada Rajeev Singh Raghuvanshi | United States India India India India | ||
| 2022-05-14 | 17744640 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | Scilex Holding Company | Abandoned -- Incomplete Application (Pre-examination) | Sagar Munjal Ankit Baheti Bijay Kumar Padhi Supritha Vakada Rajeev Singh Raghuvanshi | United States India India India India | ||
| 2021-09-10 | 17471858 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | Scilex Holding Company | Abandoned -- Failure to Respond to an Office Action | US20220241298A1 | Ankit BAHETI Bijay Kumar PADHI Supritha VAKADA Rajeev Singh RAGHUVANSHI | India India India India | SCHMITT, MICHAEL J |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |